Blog
RSS FeedPosted by Michael Wonder on 04 Jul 2016
Infringement procedure against Roche – EMA update
4 July 2016 - The EMA has concluded its second inquiry within the framework of its infringement procedure against Roche. ...
Posted by Michael Wonder on 23 Jun 2016
EMA workshop on single-arm trials in oncology
23 June 2016 - The EMA has published the agenda for the upcoming workshop. ...
Posted by Michael Wonder on 10 Jun 2016
Regulator says too many drug makers chasing same cancer strategy
10 June 2016 - A new type of cancer drug that takes the brakes off the body's immune system has given ...
Posted by Michael Wonder on 03 Jun 2016
Regulation of advanced therapy medicines
3 June 2016 - Report details concrete proposals to encourage development and authorisation of advanced therapy medicinal products (ATMPs) in the ...
Posted by Michael Wonder on 01 Jun 2016
First statistics on PRIME are released
1 June 2016 - Four medicines in development are accepted under the scheme. ...
Posted by Michael Wonder on 11 May 2016
Supporting innovative SMEs as major drivers of new pharmaceutical developments
12 May 2016 - EMA publishes report on the first ten years of its SME initiative. ...
Posted by Michael Wonder on 11 May 2016
The European Medicines Agency is still too close to industry
6 May 2016 - Two decades after its inception, the agency still fails to put patients’ interests first. ...
Posted by Michael Wonder on 04 May 2016
'It's a very good start' – funding boost for Pharmac welcomed, but is it enough?
5 May 2016 - A top health expert has praised the Government's multi-million dollar funding boost to its pharmaceutical agency Pharmac, ...
Posted by Michael Wonder on 04 May 2016
$124 million increase over four years for investment in new medicines
4 May 2016 - Medicines New Zealand is pleased that the New Zealand Government has today announced a $124 million increase ...
Posted by Michael Wonder on 03 May 2016
Federal Budget 2016 – commitment to the PBS
3 May 2016 - The innovative medicines industry acknowledges the Australian Government’s commitment to maintaining funding levels within the Federal Budget ...
Posted by Michael Wonder on 02 May 2016
France gets G7 to discuss global regulation of medicine prices
2 May 2016 - France will press its G7 partners this month to launch an "irreversible" process to control the prices ...
Posted by Michael Wonder on 02 May 2016
Are the days of big pharma dominating the agenda of a PBAC meeting over?
2 May 2016 - The sponsor with the most number of submissions on the agenda for the next PBAC meeting ...
Posted by Michael Wonder on 29 Apr 2016
Productivity Commission draft report on intellectual property arrangements
29 April 2016 - Medicines Australia notes the release of the draft report from the Productivity Commission concerning Australia’s Intellectual Property ...
Posted by Michael Wonder on 28 Apr 2016
Big pharma gaming patents for extra cash: Productivity Commission
29 April 2016 - Global pharmaceutical giants are boosting revenues by unnecessarily extending patents in Australia, which is also slowing access ...
Posted by Michael Wonder on 27 Apr 2016
Medicines New Zealand has never threatened New Zealand
26 April 2016 - Recent statements in the media misrepresent the Medicines New Zealand position on the Trans-Pacific Partnership and are ...